In a recent transaction, Alfred Sandrock, President and CEO of Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotech company with a market capitalization of $240 million and strong financial health ...

Voyager Therapeutics Inc . (NASDAQ:VYGR) stock has reached a 52-week low, touching down at $4.12. According to InvestingPro analysis, the stock's RSI indicates oversold territory, while the company ...

Wells Fargo lowered the firm’s price target on Voyager Therapeutics (VYGR) to $12 from $14 and keeps an Overweight rating on the shares. With ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...

Company to assess alternate payloads; no changes planned to novel capsid component - - Resulting shift of timeline and costs extends cash ...

Starforge Systems can build a capable gaming PC, that's for sure. But is notable aesthetic customization enough to set this ...

Security researchers warn of possible attacks on Voyager. So far, the developers have not commented on the security ...

Jan. 28, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BOSTON, Jan. 27, 2025 /PRNewswire/ -- Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert ...